Characterizing expected benefits of biomarkers in treatment selection.

about

Using decision lists to construct interpretable and parsimonious treatment regimes.Evaluating Biomarkers for Guiding Treatment Decisions.

P2860

Q36470116-F8364F7F-9B2F-429C-BC4C-CDE64763E0A9 Q37155171-E42F851D-CEC5-4146-8BDE-54254BA9FEB6

P2860

Characterizing expected benefits of biomarkers in treatment selection.

Item

http://www.wikidata.org/entity/Q38914707

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Characterizing expected benefits of biomarkers in treatment selection.

@en

type

Item

label

Characterizing expected benefits of biomarkers in treatment selection.

@en

prefLabel

Characterizing expected benefits of biomarkers in treatment selection.

@en

P1476

Characterizing expected benefits of biomarkers in treatment selection.

@en

P2093

Eric B Laber

http://www.w3.org/2001/XMLSchema#string

Ying Huang

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Method for evaluating prediction models that apply the results of randomized trials to individual patients

Using relative utility curves to evaluate risk prediction.

Analysis of randomized comparative clinical trial data for personalized treatment selections

Subgroup identification from randomized clinical trial data.

Assessing risk prediction models in case-control studies using semiparametric and nonparametric methods.

Assessing treatment-selection markers using a potential outcomes framework.

A framework for quantifying net benefits of alternative prognostic models.

A robust method for estimating optimal treatment regimes.

Estimating Individualized Treatment Rules Using Outcome Weighted Learning

P304

383-399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BIOSTATISTICS/KXU039

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Holly Janes

P577

2014-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25190512

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

4786637

http://www.w3.org/2001/XMLSchema#string

Characterizing expected benefits of biomarkers in treatment selection.

about

P2860

P2860

Characterizing expected benefits of biomarkers in treatment selection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932